Literature DB >> 833925

Effect of cyclophosphamide in vitro and on vaccinia virus replication in tissue culture.

A H Ginsberg, W T Monte, K P Johnson.   

Abstract

The effect of cyclophosphamide on the growth of Vero, BSC-1, and HeLa cells in monolayer cultures was studied. By using hemocytometer counts and tritiated thymidine uptake as indicators of growth, it was found that cyclophosphamide significantly interfered with the metabolism of Vero and BSC-1 cells when sustained in Leibovitz medium. Vero cells and HeLa cells grown in Eagle medium were not affected by exposure to cyclophosphamide. Vaccinia virus replication in Vero cell monolayer cultures incubated with cyclophosphamide was markedly augmented, and this enhanced growth was reflected by virus quantitation techniques and metabolic studies using tritiated thymidine uptake. No difference in the distribution of infectious particles was found when cyclophosphamide-treated and control infected cultures were compared. Pathways other than through hepatic enzymes appear available to activate cyclophosphamide in vitro. These effects are dependent on both the cell type and the medium in which the cells are grown. Cyclophosphamide can facilitate vaccinia virus replication in vitro through metabolic interactions at the cellular level. The precise mechanisms underlying this effect require further study.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 833925      PMCID: PMC353813          DOI: 10.1128/JVI.21.1.277-283.1977

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  10 in total

1.  Studies on the mechanism of action of cytoxan. Evidence of activation in vivo and in vitro.

Authors:  G E FOLEY; O M FRIEDMAN; B P DROLET
Journal:  Cancer Res       Date:  1961-01       Impact factor: 12.701

2.  Inhibition of host protein synthesis by vaccinia virus: fate of cell mRNA and synthesis of small poly (A)-rich polyribonucleotides in the presence of actinomycin D.

Authors:  H Rosemond-Hornbeak; B Moss
Journal:  J Virol       Date:  1975-07       Impact factor: 5.103

3.  Bioassay and relative cytotoxic potency of cyclophosphamide metabolites generated in vitro and in vivo.

Authors:  N E Sladek
Journal:  Cancer Res       Date:  1973-06       Impact factor: 12.701

4.  Activation of virus production in vaccinia virus transformed cells by methotrexate.

Authors:  J Koziorowska; B Chlopkiewicz
Journal:  Arch Gesamte Virusforsch       Date:  1973

5.  Mechanism of recovery from systemic infection with vaccinia virus. 3. Effects of antithymocyte serum.

Authors:  M Worthington
Journal:  J Infect Dis       Date:  1973-05       Impact factor: 5.226

6.  Therapeutic efficacy of cyclophosphamide as a function of its metabolism.

Authors:  N E Sladek
Journal:  Cancer Res       Date:  1972-03       Impact factor: 12.701

7.  Defective viral particles and viral disease processes.

Authors:  A S Huang; D Baltimore
Journal:  Nature       Date:  1970-04-25       Impact factor: 49.962

8.  Infections in the immunosuppressed patient.

Authors:  J M O'Loughlin
Journal:  Med Clin North Am       Date:  1975-03       Impact factor: 5.456

9.  5-iododeoxyuridine potentiation of the replication in vitro of several unrelated RNA and DNA viruses.

Authors:  J A Green; S Baron
Journal:  Science       Date:  1975-12-12       Impact factor: 47.728

10.  Mechanism of recovery from systemic vaccinia virus infection. I. The effects of cyclophosphamide.

Authors:  M Worthington; A S Rabson; S Baron
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

  10 in total
  2 in total

1.  Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer.

Authors:  Simona Bramante; Anniina Koski; Ilkka Liikanen; Lotta Vassilev; Minna Oksanen; Mikko Siurala; Raita Heiskanen; Tiina Hakonen; Timo Joensuu; Anna Kanerva; Sari Pesonen; Akseli Hemminki
Journal:  Oncoimmunology       Date:  2015-08-27       Impact factor: 8.110

2.  Cultures of Chlamydia trachomatis in mouse peritoneal macrophages: factors affecting organism growth.

Authors:  C C Kuo
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.